Sangamo Therapeutics Inc.

0.57
-0.09 (-13.08%)
At close: Apr 01, 2025, 3:59 PM
0.57
0.85%
After-hours: Apr 01, 2025, 07:46 PM EDT

Sangamo Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 41.92M 45.2M 100.44M 178.87M 131.33M
Short-Term Investments n/a 35.8M 177.19M 197.68M 510.09M
Long-Term Investments n/a n/a 29.84M 88.17M 50.53M
Other Long-Term Assets 15.19M 18.13M 12.25M 10.17M 7.87M
Receivables 526K 1.33M 4.47M 6.36M 6.26M
Inventory n/a n/a 1.00 -88.17M -50.53M
Other Current Assets 9.25M 12M 18.22M 15.86M 11.99M
Total Current Assets 51.69M 94.33M 300.33M 398.77M 659.67M
Property-Plant & Equipment 34.76M 52.87M 125.53M 124.7M 112.37M
Goodwill & Intangibles n/a n/a 88.28M 93.46M 100.93M
Total Long-Term Assets 49.94M 70.99M 262.18M 323.15M 278.88M
Total Assets 101.64M 165.32M 562.51M 721.92M 938.55M
Account Payables 15.48M 15.26M 22.42M 9.76M 12.55M
Deferred Revenue 7.56M n/a 51.78M 85.71M 96.64M
Short-Term Debt n/a n/a n/a n/a n/a
Other Current Liabilities 14.57M 11.73M 11.88M 7.55M 96.64M
Total Current Liabilities 45.8M 47.73M 111.71M 127.89M 143.55M
Long-Term Debt 26.25M n/a n/a n/a n/a
Other Long-Term Liabilities 6.81M 1.19M 1.21M 1.22M 7.01M
Total Long-Term Liabilities 33.06M 34.7M 155.84M 218.69M 297.64M
Total Liabilities 78.86M 82.43M 267.55M 346.58M 441.18M
Total Debt 30.57M 38.1M 43.11M 48.08M 42.09M
Common Stock 2.13M 1.78M 1.67M 1.46M 1.42M
Retained Earnings -1.5B -1.41B -1.15B -956.27M -777.98M
Comprehensive Income -7.53M -4.59M -8.4M -3.99M 5.42M
Shareholders Equity 22.77M 82.89M 294.96M 375.34M 497.37M
Total Investments n/a 35.8M 207.03M 285.85M 560.62M